You are here

Research News

Particularly Serious: Antidepressants, Drugs for Parkinson’s and Epilepsy
Drug “Remarkably Effective” at Killing Range of Gram-Positive Bacteria
Up to 70% Greater Risk of Bacterial Infection, 48% Risk for Fungal Infection
Most Women Undergoing Surgery for Suspected Cancer Do Not Have It
Beagles Beat Out Advanced Technology
Spina Bifida, Cleft Lip Among Defects Caused by Antiepilectics
Teplizumab Slows Progression to Disease by at Least Two 2 Years
Researchers Extend Previous Data, Find Association is Reversed
New Test Could Prevent Short- and Long-term Complications
“Baltimore Score” Outperforms Existing Prediction Models
Benefit Seen After 3 Years of Continuous Use
Inhalers Can Reduce Risk by 30% Vs. Beta Agonists
Early Statin Treatment Could Yield Long-term Benefits
Mode Delivers Antivirals Safely, Cheaply to Remote Regions
Risk May Remain for 6 Months After Treatment
May Lead to Personalized Treatment for Schizophrenia, Other Illnesses
New Technique Could Benefit Patients With End-stage Lung Disease
Vaccine Can Prevent Painful Rash That Could Cause Vision Loss
Axonal Fusion Process Could Someday Translate to Humans
Neurofilament Light Protein Correlated With Accumulated Brain Damage
Hope for Sufferers With Post-Treatment Lyme Disease Syndrome
Antibiotics, Statins, and Glucocorticoids All Show Promise
Potential For Use Against E. Coli, TB, Resistant Bacteria
Drug Improved or Stabilized Symptoms, Shrank Brain Lesions
Drug Candidate May Prevent Virus From Fusing With Epithelial Cells, B Cells
Optogenetics Provides Insights Into Basis of Fear, Addiction